
Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited
Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited

Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited

Cipla to continue slashing cancer drug prices

Bayer challenges 'compulsory license' ruling

Compulsory licensing effect: Cipla slashes price of generic cancer drug by 80%!

Roche Holding plans to launch two blockbuster cut-price cancer drugs in India

Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited

Cipla to continue slashing cancer drug prices

Bayer challenges 'compulsory license' ruling

Compulsory licensing effect: Cipla slashes price of generic cancer drug by 80%!

Roche Holding plans to launch two blockbuster cut-price cancer drugs in India